Figure 1.
CV risk factors women at the time of menopause stratified according to suitability for MHT use.
ASCVD, atherosclerotic cardiovascular disease; BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; CV, cardiovascular; E2, estradiol; HTN, hypertension; MHT, menopause hormone therapy; MI, myocardial infarction; PAD, peripheral artery disease; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; TIA, transient ischemic attack; TG, triglycerides.
